{
    "type": "ETP",
    "ucits": false,
    "replication_method": "physical",
    "leverage": true,
    "derivatives": false,
    "swaps": false,
    "inverse": true,
    "complex_factors": [
        "Leverage",
        "Inverse Exposure",
        "Daily Compounding Effect",
        "Short Exposure to Bond ETF"
    ],
    "classification": "complex",
    "supporting_data": "The product is a Collateralised Exchange Traded Security (ETP) that seeks to provide -5 times the daily performance of the iShares 20+ Year Treasury Bond ETF. It uses physical replication by holding short positions in the underlying ETF shares and cash balances, with no indication of synthetic replication or swap usage. The product is explicitly leveraged with a factor of -5x and inverse exposure, which is a key complexity trigger under MiFID II. The KIID and PRIIPs documents emphasize the daily rebalancing and compounding effects, which can cause returns over periods longer than one day to deviate significantly from the expected multiple of the underlying ETF's performance. The risk indicator is at the highest level (7/7), reflecting very high risk and complexity. There is no capital protection, and the product is intended only for sophisticated investors able to monitor their positions daily. No derivative instruments or swap agreements are used inherently in the strategy, but the leverage and inverse nature, combined with daily compounding, create complexity. The product is not UCITS compliant. The complexity arises primarily from the leverage, inverse exposure, and the daily compounding effect, which can be difficult for retail investors to understand and manage. There are no references to contingent bonds, structured products, or derivative counterparty risk. Costs are straightforward with no performance fees or swap fees. Overall, despite physical replication and no derivatives, the high leverage and inverse exposure classify this ETP as complex under MiFID II."
}